Current Trends and Investigative Developments in Celiac Disease

REFERENCES

• Aziz, I., Evans, K. E., Papageorgiou, V., Sanders, D. S. (2011). Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?J. Gastrointestin. Liver Dis. 20:27–31.
   PubMed Web of Science ®Google Scholar
• Badarau, E., Collighan, R. J., Griffin, M. (2011). Recent advances in the development of tissue transglutaminase (TG2) inhibitors. Amino Acids 44:119–27.
   PubMedGoogle Scholar
• Bayardo, M., Punzi, F., Bondar, C., Chopita, N., Chirdo, F. (2012). Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine. Clin. Exp. Immunol. 168:95–104.
   PubMedGoogle Scholar
• Caron, N. S., Munsie, L. N., Keillor, J. W., Truant, R. (2012). Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells. PLoS One 7:e44159.
   PubMed Web of Science ®Google Scholar
• Cederborg, A. C., Hultman, E., Magnusson, K. F. (2012). Living with children who have coeliac disease: a parental perspective. Child Care Health Dev. 38:484–489
   Google Scholar
• Comino, I., Real, A., de Lorenzo, L., Cornell, H., López-Casado, M. Á., Barro, F., Lorite, P., Torres, M. I., Cebolla, A., Sousa, C. (2011). Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity incoeliac disease. Gut 60:915–922.
   Google Scholar
• Comino, I., Real, A., Gil-Humanes, J., Pistón, F., de Lorenzo, L., Moreno, M. D., López-Casado, M. A., Lorite, P., Cebolla, A., Torres, M. I., Barro, F., Sousa, C. (2012). Significant differences in coeliac immunotoxicity of barley varieties. Mol. Nutr. Food Res. 56:1697–1707.
   Google Scholar
• Crespo Pérez, L., Castillejo de Villasante, G., Cano Ruiz, A., León, F. (2012). Non-dietary therapeutic clinical trials in coeliac disease. Eur. J. Intern. Med. 23:9–14.
   PubMedGoogle Scholar
• De Re, V., Simula, M. P., Canzonieri, V., Cannizzaro, R. (2010). Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. Dig. Dis. Sci. 55:3041–3046.
   Google Scholar
• Diaz-Amigo, C., Popping, B. (2012). Gluten and gluten-free: issues and considerations of labeling regulations, detection methods, and assay validation. J. AOAC Int. 95:337–348.
   Google Scholar
• Ehren, J., Morón, B., Martin, E., Bethune, M. T., Gray, G. M., Khosla, C. (2009). A food-grade enzyme preparation with modest gluten detoxification properties. PLoS One 4:e6313.
   PubMed Web of Science ®Google Scholar
• Eksteen, B., Adams, D. H. (2010). GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs 13:472–481.
   Google Scholar
• Ferranti, P., Mamone, G., Picariello, G., Addeo, F. (2007). Mass spectrometry analysis of gliadins in celiac disease. J. Mass Spectrom. 42:1531–1548.
   Google Scholar
• Ferretti, G., Bacchetti, T., Masciangelo, S., Saturni, L. (2012). Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients4:243-257.
   Google Scholar
• Freeman HJ. 2012. Celiac disease and selected long-term health issues. Maturitas 73:206–211.
   Google Scholar
• Gopalakrishnan, S., Durai, M., Kitchens, K., Tamiz, A. P., Somerville, R., Ginski, M., Paterson, B. M., Murray, J. A., Verdu, E. F., Alkan, S. S., Pandey, N. B. (2012a). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides 35:86–94.
   PubMedGoogle Scholar
• Gopalakrishnan, S., Tripathi, A., Tamiz, A. P., Alkan, S. S., Pandey, N. B. (2012b). Larazotide acetate promotes tight junction assembly in epithelial cells. Peptides 35:95–101.
   PubMedGoogle Scholar
• Kasarda, D. D., Dupont, F. M., Vensel, W. H., Altenbach, S. B., Lopez, R., Tanaka, C. K., Hurkman, W. J. (2008). Surface-associated proteins of wheat starch granules: Suitability of wheat starch for celiac patients. J. Agric. Food Chem. 56:10292-10302.
   Google Scholar
• Kaukinen, K., Ilus, T., Vornanen, M., Collin, P. (2012). When gluten-free diet does not cure celiac disease. Duodecim 128:945-951.
   Google Scholar
• Koning F. (2012). Celiac disease: quantity matters. Semin Immunopathol 34: 541-9
   PubMedGoogle Scholar
• Lähdeaho, M. L., Lindfors, K., Airaksinen, L., Kaukinen, K., Mäki, M. (2012). Recent advances in the development of new treatments for celiac disease. Expert Opin. Biol. Ther. 12:1589–1600.
   Google Scholar
• Leffler, D. A., Kelly, C. P., Abdallah, H. Z., Colatrella, A. M., Harris, L. A., Leon, F., Arterburn, L. A., Paterson, B. M., Lan, Z. H., Murray, J. A. (2012). A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am. J. Gastroenterol. 107:1554–1562.
   Google Scholar
• Li, J., Wang, S., Li, S., Ge, P., Li, X., Ma, W., Zeller, F. J., Hsam, S. L., Yan, Y. (2012). Variations and classification of toxic epitopes related to celiac disease among α-gliadin genes from four Aegilops genomes. Genome 55:513–521.
   Google Scholar
• Luciani, A., Villella, V. R., Vasaturo, A., Giardino, I., Pettoello-Mantovani, M., Guido, S., Cexus, O. N., Peake, N., Londei, M., Quaratino, S., Maiuri, L. (2010). Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut 59:311–319.
   Google Scholar
• Mamone, G., Camarca, A., Fierro, O., Sidney, J., Mazzarella, G., Addeo, F., Auricchio, S., Troncone, R., Sette, A., Gianfrani, C. (2012). Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication for searching of gluten-free cereals. J Agric Food Chem 61:747–54.
   Google Scholar
• Mamone, G., Picariello, G., Addeo, F., Ferranti, P. (2011). Proteomic analysis in allergy and intolerance to wheat products. Expert Rev. Proteomics 8:95–115.
   PubMedGoogle Scholar
• McAllister, C. S., Kagnoff, M. F. (2012). The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin. Immunopathol. 34:581–600.
   PubMedGoogle Scholar
• McSorley, H. J., Gaze, S., Daveson, J., Jones, D., Anderson, R. P., Clouston, A., Ruyssers, N. E., Speare, R., McCarthy, J. S., Engwerda, C. R., Croese, J., Loukas, A. (2011). Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 6:e24092.
   PubMed Web of Science ®Google Scholar
• Mitea, C., Havenaar, R., Drijfhout JW, Edens L, Dekking L, Koning F. 2008. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 57: 25–32.
   PubMedGoogle Scholar
• Mitea, C., Salentijn, E. M., van Veelen, P., Goryunova, S. V., van der Meer, I. M., van den Broeck, H. C., Mujico, J. R., Monserrat, V., Gilissen, L. J., Drijfhout, J. W., Dekking, L., Koning, F., Smulders, M. J. (2010). A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One 5: e15637.
   PubMed Web of Science ®Google Scholar
• Morón, B., Bethune, M. T., Comino, I., Manyani, H., Ferragud, M., López, M. C., Cebolla, A., Khosla, C., Sousa, C. (2008). Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One 3:e2294.
   PubMed Web of Science ®Google Scholar
• Pinier, M., Fuhrmann, G., Galipeau, H. J., Rivard, N., Murray, J. A., David, C. S., Drasarova, H., Tuckova, L., Leroux, J. C., Verdu, E. F. (2012). The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology 142:316–325.
   Google Scholar
• Pinier, M., Verdu, E. F., Nasser-Eddine, M., David, C. S., Vézina, A., Rivard, N., Leroux, J. C. (2009). Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 136:288–298.
   Web of Science ®Google Scholar
• Rashtak, S., Murray, J. A. (2012). Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol. Ther. 35:768–781.
   Google Scholar
• Rauhavirta, T., Oittinen, M., Kivistö, R., Männistö, P. T., Garcia-Horsman, J. A., Wang, Z., Griffin, M., Mäki, M., Kaukinen, K., Lindfors, K. (2012). Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study. J. Clin. Immunol.33:134–42.
   Google Scholar
• Richman, E. (2012). The safety of oats in the dietary treatment of coeliac disease. Proc. Nutr. Soc. 71:534-537.
   Google Scholar
• Salentijn, E. M., Mitea, D. C., Goryunova, S. V., Van der Meer, I. I., Padioleau, I., Gilissen, L. J., Koning, F., Smulders, M. J. (2012). Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics 13:277.
   PubMed Web of Science ®Google Scholar
• Samaşca, G., Iancu, M., Pop, T., Butnariu, A., Andreica, M., Cristea, V., Dejica, D. (2011). Importance of the educational environment in the evolution of celiac disease. Lab Med. 42:497–501.
   Google Scholar
• Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., Ullrich, R., Villalta, D., Volta, U., Catassi, C., Fasano, A. (2012). Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Med 10:13.
   PubMed Web of Science ®Google Scholar
• Siegel, M., Garber, M. E., Spencer, A. G., Botwick, W., Kumar, P., Williams, R. N., Kozuka, K., Shreeniwas, R., Pratha, V., Adelman, D. C. (2012). Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig. Dis. Sci. 57:440–450.
   Google Scholar
• Silano, M., Vincentini, O., Luciani, A., Felli, C., Caserta, S., Esposito, S., Villella, V. R., Pettoello-Mantovani, M., Guido, S., Maiuri, L. (2012). Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin-dependent agglutination. Pediatr. Res. 71:532–538.
   Google Scholar
• Skylas, D. J., Mackintosh, J. A., Cordwell, S. J., Basseal, D. J., Walsh, B. J., Harry, J., Blumenthal, C., Copeland, L., Wrigley, C. W., Rathmell, W. 2000. Proteome approach to the characterization of protein composition in the developing and mature wheat grain endosperm. J. Cereal Sci. 32:169–188.
   Google Scholar
• Thompson, T., Lee, A. R., Grace, T. (2010). Gluten contamination of grains, seeds, and flours in the United States: a pilot study. J. Am. Diet Assoc. 110:937–940.
   Google Scholar
• Tjon, J. M., van Bergen, J., Koning, F. (2010). Celiac disease: How complicated can it get? Immunogenetics 62:641–651.
   Google Scholar
• Tye-Din, J. A., Anderson, R. P., French, R. A., Brown, G. J., Hodsman, P., Siegel, M., Botwick, W., Shreeniwas, R. (2010). The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin. Immunol. 134:289–295.
   Google Scholar
• Vincentini, O., Maialetti, F., Gazza, L., Silano M., Dessi, M., De Vincenzi, M., Pogna, N. E. (2007). Environmental factors of celiac disease: cytotoxicity of hulled wheat species Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp. spelta. J. Gastroenterol. Hepatol. 22:1816–1822.
   Google Scholar
• Wan, Y., Poole, R. L., Huttly, A. K., Toscano-Underwood, C., Feeney, K., Welham, S., Gooding, M. J., Mills, C., Edwards, K. J., Shewry, P. R., Mitchell, R. A. (2008). Transcriptome analysis of grain development in hexaploid wheat. BMC Genomics 9: 121.
   PubMed Web of Science ®Google Scholar
• Wang, S., Shen, X., Ge, P., Li, J., Subburaj, S., Li, X., Zeller, F. J., Hsam, S. L., Yan, Y. (2012). Molecular characterization and dynamic expression patterns of two types of γ-gliadin genes from Aegilops and Triticum species. Theor. Appl. Genet. 125:1371–1384.
   Google Scholar